Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer.
Cancers (Basel). 2021 Nov 10;13(22):5615. doi: 10.3390/cancers13225615.
Cancers (Basel). 2021.
PMID: 34830770
Free PMC article.
Review.
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
Eickelschulte S, Riediger AL, Angeles AK, Janke F, Duensing S, Sültmann H, Görtz M.
Eickelschulte S, et al. Among authors: riediger al.
Cancers (Basel). 2022 Dec 11;14(24):6094. doi: 10.3390/cancers14246094.
Cancers (Basel). 2022.
PMID: 36551580
Free PMC article.
Review.
Item in Clipboard
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Janke F, Angeles AK, Riediger AL, Bauer S, Reck M, Stenzinger A, Schneider MA, Muley T, Thomas M, Christopoulos P, Sültmann H.
Janke F, et al. Among authors: riediger al.
Clin Epigenetics. 2022 Dec 2;14(1):163. doi: 10.1186/s13148-022-01387-4.
Clin Epigenetics. 2022.
PMID: 36461127
Free PMC article.
Item in Clipboard
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients.
Riediger AL, Dietz S, Schirmer U, Meister M, Heinzmann-Groth I, Schneider M, Muley T, Thomas M, Sültmann H.
Riediger AL, et al.
Sci Rep. 2016 Sep 19;6:33505. doi: 10.1038/srep33505.
Sci Rep. 2016.
PMID: 27640882
Free PMC article.
Item in Clipboard
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.
Dietz S, Sültmann H, Du Y, Reisinger E, Riediger AL, Volckmar AL, Stenzinger A, Schlesner M, Jäger D, Hohenfellner M, Duensing S, Grüllich C, Pahernik S.
Dietz S, et al. Among authors: riediger al.
Oncotarget. 2017 May 23;8(43):74049-74057. doi: 10.18632/oncotarget.18200. eCollection 2017 Sep 26.
Oncotarget. 2017.
PMID: 29088767
Free PMC article.
Item in Clipboard
Cite
Cite